MONTRÉAL, Aug. 27, 2026 /CNW/ -- ISOLOGIC Innovative Radiopharmaceuticals invites media representatives to the official inauguration of its new Lachine facility, one of the most advanced nuclear medicine infrastructures in Canada, alongside elected officials, partners, and clients.

The event will include an exclusive tour of the state-of-the-art facility. This $30 million investment will expand national production capacity for essential radiopharmaceuticals while ensuring a more reliable supply for healthcare institutions across the country.

Date: Tuesday, September 1, 2026
Time: 4:30 PM
Location: 1855 32nd Avenue
Lachine (Montreal), QC H8T 3J1

Morning time slots are also available for media wishing to film inside the facility.

As a Canadian leader in nuclear medicine, ISOLOGIC currently supplies nearly 230 hospitals and healthcare institutions nationwide. Each year, its products contribute to the diagnosis and treatment of over 650,000 Canadian patients.

SOURCE ISOLOGIC Innovative Radiopharmaceuticals